FDA Inspection
Repromed Fertility CenterRepromed Fertility Center – FDA Inspection, Nov 22, 2019
Record Details
This FDA Inspection record concerns Repromed Fertility Center, with an inspection on November 22, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Repromed Fertility Center
- Inspection Date
- November 22, 2019
- Product Type
- Biologics
View Company Profile
ID · e59213dd-7bca-4a3a-affa-12b3f4068d2f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1111090
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.85(a)Infection with communicable disease agents
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Repromed Fertility Center
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 1, 2026 | Not classified | Dallas District Office | Human Cellular, Tissue, and Gene Therapies |
| July 20, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 6, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 2, 2014 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 24, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Repromed Fertility Center
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.